Nisa Investment Advisors, LLC Pacira Bio Sciences, Inc. Transaction History

Nisa Investment Advisors, LLC

$15.7 Billion
Q2 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 581 shares of PCRX stock, worth $9,598. This represents 0.0% of its overall portfolio holdings.

Number of Shares

581

Previous 535 8.6%

Holding current value

$9,598

Previous $15,000 6.67%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$25.5 - $31.51 $1,173 - $1,449	46 Added 8.6%	581 $16,000
Q1 2024 May 01, 2024	BUY	$27.7 - $35.48 $1,274 - $1,632	46 Added 9.41%	535 $15,000
Q4 2023 Jan 25, 2024	SELL	$26.32 - $34.31 $39,795 - $51,876	-1,512 Reduced 75.56%	489 $16,000
Q3 2023 Nov 02, 2023	BUY	$30.68 - $40.09 $46,449 - $60,696	1,514 Added 310.88%	2,001 $61,000
Q2 2023 Aug 11, 2023	SELL	$36.12 - $47.5 $16,217 - $21,327	-449 Reduced 47.97%	487 $19,000
Q1 2023 May 02, 2023	SELL	$35.53 - $43.38 $23,272 - $28,413	-655 Reduced 41.17%	936 $38,000
Q4 2022 Feb 02, 2023	BUY	$38.19 - $57.45 $343 - $517	9 Added 0.57%	1,591 $61,000
Q3 2022 Nov 07, 2022	SELL	$51.24 - $58.89 $6,609 - $7,596	-129 Reduced 7.54%	1,582 $82,000
Q2 2022 Aug 03, 2022	BUY	$51.49 - $81.64 $6,384 - $10,123	124 Added 7.81%	1,711 $100,000
Q1 2022 Apr 29, 2022	SELL	$60.03 - $76.49 $8,284 - $10,555	-138 Reduced 8.0%	1,587 $121,000
Q4 2021 Feb 03, 2022	SELL	$47.97 - $62.21 $184,492 - $239,259	-3,846 Reduced 69.04%	1,725 $108,000
Q3 2021 Oct 18, 2021	BUY	$54.64 - $61.3 $56,443 - $63,322	1,033 Added 22.76%	5,571 $312,000
Q2 2021 Aug 06, 2021	SELL	$59.18 - $69.99 $82,852 - $97,986	-1,400 Reduced 23.58%	4,538 $275,000
Q4 2020 Jan 25, 2021	BUY	$50.47 - $66.26 $189,918 - $249,336	3,763 Added 173.01%	5,938 $355,000
Q3 2020 Oct 20, 2020	SELL	$51.97 - $63.0 $1.1 Million - $1.33 Million	-21,146 Reduced 90.67%	2,175 $131,000
Q2 2020 Jul 27, 2020	BUY	$30.8 - $52.47 $478,354 - $814,911	15,531 Added 199.37%	23,321 $1.22 Million
Q1 2020 Apr 17, 2020	BUY	$28.4 - $50.7 $8,520 - $15,210	300 Added 4.01%	7,790 $261,000
Q4 2019 Jan 17, 2020	BUY	$36.31 - $46.83 $10,893 - $14,049	300 Added 4.17%	7,490 $339,000
Q3 2019 Oct 17, 2019	SELL	$35.66 - $44.99 $19,898 - $25,104	-558 Reduced 7.2%	7,190 $274,000
Q1 2019 Apr 17, 2019	BUY	$36.47 - $42.17 $269,805 - $311,973	7,398 Added 2113.71%	7,748 $295,000
Q4 2018 Jan 17, 2019	SELL	$41.31 - $52.16 $2,272 - $2,868	-55 Reduced 13.58%	350 $15,000
Q2 2018 Jul 19, 2018	BUY	$27.5 - $39.8 $6,325 - $9,154	230 Added 131.43%	405 $13,000
Q1 2018 Apr 10, 2018	BUY	$29.98 - $46.35 $5,246 - $8,111	175 New	175 $5,000

Others Institutions Holding PCRX

# of Institutions

302

Shares Held

51.6M

Call Options Held

378K

Put Options Held

1.53M

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $757M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Pacira Bio Sciences, Inc. Transaction History